eLearning Expands Osteoporosis Care for Underserved Communities
In this week's news roundup from Rheumatology Network, we feature a one-on-one interview with Dr. Michael Lewiecki of the New Mexico Clinical Research and Osteoporosis Center. He heads a virtual learning program called Bone Health TeleECHO and in this interview, he tells us how the program works, why it’s needed and how you, as a physician, can launch one in your state.
________
In this week's news roundup from Rheumatology Network: This week, we published an interview with Dr. Beate Wieseler of Germany who published a systematic review and meta-analysis in BMJ that compared the effectiveness of biologic drugs used to treat rheumatoid arthritis (RA) after methotrexate fails. She reported that in most cases, there is little difference in outcomes among the biologics.
We also featured a study from the European Respiratory Journal that shows methotrexate does not increase the risk of interstitial lung disease in RA. In an interview with Rheumatology Network, the author says the findings suggest that methotrexate should not be discontinued in RA patients who have ILD (interstitial lung disease).
And, we published the latest edition of our monthly column Awkward Conversations by Dr. Kim Gorgens. This month, Dr. Gorgens focuses on managing the rheumatic disease with mental illness.
Also, we posted our bimonthly RA quiz which this time focuses on screening RA patients for cardiovascular disease.
And, in this week’s edition of our podcast, Overdrive, we published an in-depth conversation with Dr. Daniel Solomon who is editor-in-chief of Arthritis and Rheumatology. We talked about COVID-19 research on hydroxychloroquine and the cytokine storm syndrome. You can find that interview on our site or download Overdrive from iTunes.
In today’s one-on-one interview, we talk Michael Lewiecki, M.D., director of the New Mexico Clinical Research and Osteoporosis Center and a University of New Mexico program called Bone Health TeleECHO. It’s a virtual program that is designed to train physicians on how best to treat osteoporosis patients. In this interview, we cover how the program works, why it’s needed and how you, as a physician, can launch one in your state.
I hope you enjoy the discussion.
____________
Fore more information about Bone Health TeleECHO, including links to information about registering for a session participating in a session or viewing existing sessions, see:
Project ECHO, Changing the World Fast
Bone Health TeleECHO Replication Video: Start Your Own Bone Health TeleECHO
Bone Health TeleECHO Participation Video: Join Bone Health TeleECHO or https://vimeo.com/246121236/76efb37b39
Bone Health TeleECHO FLS Video
